TrialDiabetes care2010

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial.

Ele Ferrannini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.